Centessa Pharmaceuticals (CNTA)

• Market cap: $3.66B
• 1 day: -2.13%
• 5 days: -1.16%
• 1 month: -12.93%
• 3 months: 1.6%
• 6 months: 88.66%
• Year to date: 41.66%
• 1 year: 51.62%
• 5 years: 13.98%
• 10 years: 13.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Employees: 114